Gnb3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
GNB3
| Symbol | GNB3 |
| Full Name | G Protein Subunit Beta 3 |
| Chromosome | 12p13.31 |
| NCBI Gene ID | 2784 |
| OMIM | 139310 |
| Ensembl ID | ENSG00000111664 |
| UniProt ID | P16520 |
| Encoded Protein | GNB3 Protein |
| Associated Diseases | Hypertension, Depression, Obesity, Parkinson's Disease |
The GNB3 gene encodes GNB3 Protein, a G protein beta subunit that plays critical roles in G-protein beta subunit mediating signal transduction. This gene is implicated in the pathogenesis of several neurodegenerative diseases through its involvement in GPCR signaling, neurotransmitter response, metabolic regulation.
GNB3 encodes the β3 subunit of heterotrimeric G proteins. The Gβγ complex, formed by GNB3 with a Gγ subunit, plays essential roles in mediating signal transduction from activated G protein-coupled receptors (GPCRs) to downstream effectors. GNB3 is widely expressed and participates in numerous signaling pathways including dopamine, serotonin, adrenergic, and muscarinic receptor signaling. A common polymorphism (C825T) in GNB3 has been associated with various phenotypes including hypertension, depression, obesity, and response to certain medications. GNB3 also plays roles in synaptic transmission and neuronal plasticity.
| Disease | Inheritance | Key Mutations |
|---|---|---|
| Hypertension | Various | Pathogenic variants |
| Depression | Various | Pathogenic variants |
| Obesity | Various | Pathogenic variants |
| Parkinson's Disease | Various | Pathogenic variants |
The GNB3 C825T polymorphism has been extensively studied for its association with cardiovascular disease, metabolic disorders, and neuropsychiatric conditions. In Parkinson's disease, GNB3 may modulate dopaminergic signaling and neuron survival. The T allele of GNB3 C825T has been associated with enhanced G-protein coupling, which may affect drug response in various conditions including depression and hypertension.
GNB3 is widely expressed throughout the body, including brain, heart, kidney, and adipose tissue. In the brain, it is expressed in various regions including the cortex, hippocampus, basal ganglia, and cerebellum.
The study of Gnb3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.